Finally, C11orf17 (A kinase interacting protein 1), MAP2K6 (mitogen-activated protein kinase kinase 6: MKK6), PARD6A (par-6 partitioning defective 6 homolog alpha), MINA (MYC induced nuclear antigen), NUDT6 (fibroblast growth factor 2: FGF-2), PSMD10 (proteasome (prosome, macropain) 26S subunit, non-ATPase, 10: p28), PSMD10, FABP3 (fatty acid binding protein 3), AMPK (AMP-activated protein kinase) and PRND (prion protein 2) have been suggested to potentially contribute towards the migratory and morphological behavioral changes of tumor cells. The gene discussed is FGF2; the disease is neoplasm.